Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

View:
Post by Possibleidiot01 on Feb 02, 2024 3:16pm

roundup

  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Stifel Nicolaus from C$20.00 to C$21.00. They now have a "buy" rating on the stock. This represents a 47.6% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Scotiabank from C$22.00 to C$24.00. They now have an "outperform" rating on the stock. This represents a 68.7% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at CIBC from C$18.00 to C$19.00. They now have an "outperform" rating on the stock. This represents a 33.5% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Raymond James from C$21.00 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.
  •  
  • DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at National Bankshares, Inc. from C$18.50 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.


Comment by HermannHaller on Feb 04, 2024 5:29pm
From Scotia:  DRI Healthcare Trust DHT.U-T: US$10.24 Target: US$24.00 Old: US$22.00 Rating: Sector Outperform Out-year Revenue Runway Enhanced; Lifting Target to $24 OUR TAKE: Positive. Lifting the cap and expanding royalty interest in sales of pipeline drug, Omidria, is very favorable to our model and significantly mitigates royalty growth concerns beyond 2026 that the trust had ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities